Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Clinical trial NCT06071897 · RECRUITING
Trial details
- NCT number
- NCT06071897
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.